BIOPHARMA HOLDING ApS: Financial statements 2019
CVR: 35206086
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
BIOPHARMA HOLDING ApS (CVR 35206086) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 385,493 and a net result of DKK 24,366,007 compared with DKK 1,373,309 the year before. That is a decrease of 4.8% compared with the year before. Equity in the 2019 report amounted to DKK 144,766,973. The solvency ratio was 97%.
- Gross Profit
- DKK 385,493
- Profit/Loss
- DKK 24,366,007
- Equity
- DKK 144,766,973
- Total Assets
- DKK 149,245,323
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 385K | 24.4M | 144.8M | 0 |
| 2018 | - | 405K | 1.4M | 120.4M | 0 |
| 2017 | - | 298K | -8.2M | 119M | 1 |
| 2016 | - | 379K | -6.9M | 127.2M | 2 |
| 2015 | - | 149K | -200.3M | 134M | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
BIOPHARMA HOLDING ApS has published its annual report for 2018. Gross profit came to DKK 404,990, and the net result was DKK 1,373,309.
About BIOPHARMA HOLDING ApS
BIOPHARMA HOLDING ApS was a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2013. The company has been dissolved on 17 July 2026. The company was registered under the industry Finansielle holdingselskaber. The company has 1 employee (2017). In 2024, the company reported a gross profit of DKK 921,360 and a net result of DKK -3,732,682 compared with DKK -20,576,349 the year before. Equity in the 2024 report amounted to DKK 2,921,095.